Healthcare Global Enterprises Limited has informed the Exchange about the approval of the Board for the introduction and adoption of ESOP Scheme 2026 subject to the shareholders approval of the Company.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has informed the stock exchange that its Board of Directors has approved the introduction and adoption of a new Employee Stock Option Plan (ESOP) called ESOP Scheme 2026. The scheme is designed to grant stock options to employees as part of their compensation. The scheme will only become effective after receiving approval from the company's shareholders. No details on the number of options, grant size, or vesting terms have been disclosed in this filing.
ESOP schemes can lead to dilution of existing shareholders' equity once options are granted and exercised, but they help attract and retain talent. Short-term stock price impact is typically neutral; the effect depends on the eventual size and terms of the scheme.